Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
FBXO2-mediated KPTN ubiquitination promotes amino acid–dependent mTORC1 signaling and tumor growth
Jianfang Gao, Jina Qing, Xianglong Li, Yuxuan Luo, Lingwen Huang, Hongxia Li, Huan Zhang, Jiao Zhang, Pei Xiao, Jinsong Li, Tingting Li, Shanping He
Jianfang Gao, Jina Qing, Xianglong Li, Yuxuan Luo, Lingwen Huang, Hongxia Li, Huan Zhang, Jiao Zhang, Pei Xiao, Jinsong Li, Tingting Li, Shanping He
View: Text | PDF
Research Article Cell biology Oncology

FBXO2-mediated KPTN ubiquitination promotes amino acid–dependent mTORC1 signaling and tumor growth

  • Text
  • PDF
Abstract

Mechanistic target of rapamycin complex 1 (mTORC1) is a master controller of cell growth, and its dysregulation is associated with cancer. KICSTOR, a complex comprising KPTN, ITFG2, C12orf66, and SZT2, functions as a critical negative regulator of amino acid–induced mTORC1 activation. However, the regulatory mechanisms governing KICSTOR remain largely unclear. In this study, we identify F-box only protein 2 (FBXO2) as a key modulator of amino acid–dependent mTORC1 signaling. Mechanistically, FBXO2 colocalizes and directly interacts with KPTN via its F-box–associated domain, promoting K48- and K63-linked polyubiquitination of KPTN at lysine residues 49, 67, 262, and 265. FBXO2-mediated KPTN ubiquitination disrupted its interaction with ITFG2 and SZT2, while enhancing its interaction with C12orf66, thereby impairing the ability of KICSTOR to recruit the GATOR1 complex — comprising DEPDC5, NPRL2, and NPRL3 — to the lysosomal surface. Notably, FBXO2 protein levels were substantially upregulated in patients with liver cancer, and FBXO2-mediated KPTN ubiquitination facilitated the progression of hepatocellular carcinoma (HCC). These results reveal a key regulatory mechanism of mTORC1 signaling and highlight FBXO2 and KPTN ubiquitination as therapeutic targets for HCC treatment.

Authors

Jianfang Gao, Jina Qing, Xianglong Li, Yuxuan Luo, Lingwen Huang, Hongxia Li, Huan Zhang, Jiao Zhang, Pei Xiao, Jinsong Li, Tingting Li, Shanping He

×

Figure 2

FBXO2 directly binds to KPTN via its F-box–associated domain.

Options: View larger image (or click on image) Download as PowerPoint
FBXO2 directly binds to KPTN via its F-box–associated domain.
(A and B) ...
(A and B) HEK293T cells stably expressing Flag-tagged RagA-Q66L (Flag-RagA-Q66L) (A) or NPRL2-knockout cells (B) were transduced with lentiviruses expressing either shCTL or shFBXO2 for 72 hours, deprived of amino acids and serum for 2 hours, and then stimulated with amino acids for 10 minutes. WCLs were analyzed by immunoblotting with the indicated antibodies. (C) Wild-type (WT), KPTN-knockout, or NPRL2-knockout HEK293T cells were transduced with lentiviruses expressing Flag-FBXO2. (D and E) HEK293T cells stably expressing Flag-FBXO2 (D) or KPTN-knockout HEK293T cells (E) were transfected with plasmids containing the indicated genes. WCLs (C–E) were immunoprecipitated with anti-Flag (C) or anti-HA (D and E) magnetic beads, followed by immunoblotting with the indicated antibodies. (F) HEK293T cells were cotransfected with plasmids expressing mCherry-C160–tagged FBXO2 (mCherry-C160-FBXO2) and mCherry-N159–tagged SKP1, KPTN, or Raptor, followed by nucleus staining with DAPI. Representative images of mCherry were shown. Scale bar, 100 μm. (G) HeLa cells stably expressing Flag-FBXO2 were subjected to immunofluorescence assays with the indicated antibodies. Scale bar, 10 μm. (H) Schematic diagram of the domains of FBXO2. FBA, F-box–associated. (I) WCLs of HEK293T cells transfected with plasmids expressing HA-tagged FBXO2 or its mutant FBXO2-Y279A/W280A were incubated with purified GST-tagged KPTN (GST-KPTN) or GST proteins from bacteria, followed by in vitro GST pulldown assays. GST, glutathione-S-transferase. (J) Diagram of FBXO2 interacting with KPTN rather than other components of KICSTOR or GATOR1. (K) WT or KPTN-knockout HEK293T cells were transduced with lentiviruses expressing either shCTL or shFBXO2 for 72 hours, deprived of amino acids and serum for 2 hours, and then stimulated with amino acids for 10 minutes. WCLs were analyzed by immunoblotting with the indicated antibodies. Data are representative of at least 2 independent experiments (A–E, I, and K).

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts